Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enveric Biosciences Inc (ENVB) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance

Enveric Biosciences IncTrade
Ionis Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Enveric Biosciences Inc vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? Enveric Biosciences Inc trades at $1.2 (market cap $6.27M), while Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 1122.8× Enveric Biosciences Inc's market cap, and Enveric Biosciences Inc is more actively traded (100,675 versus 2,977,440). Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.

ENVBIONS
Market Cap
$6.27M$7.04B
Volume
100,6752,977,440
Sector
HealthHealth
52-Week High
$10.80$86.50
52-Week Low
$1.27$42.38
Typical Hold Time
14 Days0 Days
Enterprise Value
-$2.03M$6.60B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enveric Biosciences Inc

ENVB trades at $1.40, down 4.76% with a bearish technical signal from moving averages. The company shows negative profitability metrics with ROE at -235.48% and no revenue in 2025, though it has consistently beaten EPS estimates. Recent news highlights patent approvals and positive preclinical data for its neuroplastogenic therapeutics.

The outlook remains speculative given the lack of revenue and negative cash flow from operations. Analyst consensus is 75% buy, but high business execution risks and dependence on drug development success pose significant challenges for near-term shareholder value.

Ionis Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ENVB

No sentiment data available yet.

IONS
100% Buy0% Sell
Avg holding period · 0 Days

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB →

About Ionis Pharmaceuticals Inc. Common Stock

Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.

Read more on IONS →